Transition from intravenous to subcutaneous biological therapies in inflammatory bowel disease: An online survey of patients

ConclusionThe transition from in-hospital to subcutaneous therapeutic management of biological therapy at home was generally viewed favorably by patients, especially if they have commitments or were residents far from the IBD center.Graphical abstract
Source: Indian Journal of Gastroenterology - Category: Gastroenterology Source Type: research